Protecting the Unique Pharma/Life Sciences Business Model When Working With Compliance Monitors and/or Consultants
April 28, 2008
On April 28, 2008, David Samson spoke at ACI’s FCPA and International Anti-Corruption for the Pharma & Life Sciences Industries conference in New York. David Samson's session was entitled, Protecting the Unique Pharma/Life Sciences Business Model When Working With Compliance Monitors and/or Consultants. For further information contact David Samson at (973)530-2000 or via e-mail at: dsamson@wolffsamson.com.
